Other lipid agents × lipids

TrialClinical cardiology1999

Long-term safety of pravastatin-gemfibrozil therapy in mixed hyperlipidemia.

E A Iliadis et al.PubMed ↗Full text ↗Publisher ↗

What the trial testedas reported · 1999

No range given

Reported lower lipids, no range given

−25.0percentage points

As reported

difference −25.0 %, no interval

One number in the abstract

the abstract, start to end

mg) therapy lowered total cholesterol by 25% (p < 0.001), triglycerides by

← favours treatmentfavours comparator →
could be chance
No interval given · direction only, strength unknown
Lipids
−25.0
StatinsOther lipid agentsLipids

Other lipid agents × lipidshelps?mixed

unlikelylikely
0.500.50 without it

Statins × lipidshelps?mixed

unlikelylikely
0.500.50 without it
← favours treatmentfavours comparator →
this papermore certainless certain
1 / 5

7 papers cite it

1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 9929751